A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client-owned dogs with allergic dermatitis
CONCLUSIONS AND CLINICAL IMPORTANCE: Lokivetmab is a safe and efficacious treatment for dogs with allergic dermatitis.PMID:34180084 | DOI:10.1111/vde.12984
Source: Veterinary Dermatology - Category: Veterinary Research Authors: Leen Van Brussel Hilde Moyaert Monica Escalada Sean P Mahabir Michael R Stegemann Source Type: research
More News: Allergy & Immunology | Clinical Trials | Dermatitis | Dermatology | France Health | Germany Health | Hungary Health | Portugal Health | Primary Care | Skin | Veterinary Research